Remove 2006 Remove Safety Remove Treatment
article thumbnail

Australia – Policy Analysis: Medicinal cannabis and driving: the intersection of health and road safety policy – “there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications”

Cannabis Law Report

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Faculty of Science, School of Psychology, The University of Sydney, Sydney, NSW 2006, Australia.

article thumbnail

Policy Analysis Paper: Medicinal cannabis and driving: the intersection of health and road safety policy

Cannabis Law Report

Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. Faculty of Science, School of Psychology, The University of Sydney, Sydney, NSW 2006, Australia. methadone) demonstrate a feasible alternative approach. Conclusion. S0955395921002127-main.

Policy 51
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Benefits of Cannabis for Alzheimer’s disease

Alchimia

Although a balanced nutrition – and regular brain stimulation – can have protective and preventive effects , we still don’t have any effective treatment for Alzheimer’s disease once it is active. Cannabinoids for treatment of Alzheimer?s Published in the Molecular Pharmaceutics magazine, November 2006.

article thumbnail

A Patient’s Guide to CBD and Drug Interactions

Healer

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Some compounds work synergistically with CBD, so asking your doctor can help you maximize the effect of your treatment.

CBD 98
article thumbnail

Italy: MINISTRY OF HEALTH DECREE – Definition of maximum levels of tetrahydrocannabinol (THC) in food

Cannabis Law Report

the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no. 1881/2006 of the Commission dated 19. December 2006 which defines the maximum levels of some contaminants. food): «Scientific Opinion on the safety of hemp (Cannabis. regulations (EC) no.

Food 45
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).